company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,17008000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1416000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,40583000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,15961000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,898000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,260000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,3751000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,79877000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1537000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,12984000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,14014000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,26998000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,,totalassets,Total Assets,=,debit,usd,108412000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5012000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12309000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3321000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,1318000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,21960000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,14846000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2340000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,47186000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,69146000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,365044000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-325870000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,92000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,39266000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,39266000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,39266000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,,2011-06-30,2011-08-04 17:05:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,108412000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,22441000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,625000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,21558000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,11634000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,898000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,795000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2495000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,60446000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1353000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,16416000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,14296000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,30712000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,,totalassets,Total Assets,=,debit,usd,92511000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3583000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12030000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3370000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,350000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,19333000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,14210000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2926000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,47136000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,66469000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,366320000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-340328000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,50000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,26042000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,26042000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,26042000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,,2011-09-30,2011-11-03 17:20:37+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,92511000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,27661000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,955000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,15617000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5852000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,263000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,407000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2194000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,52949000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,999000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,13067000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,13070000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,26137000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,,totalassets,Total Assets,=,debit,usd,80085000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2062000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9253000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2400000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,2450000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16165000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6808000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3962000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,40770000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,56935000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,382673000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-359572000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,49000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,23150000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,23150000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,23150000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,,2012-03-31,2012-05-08 15:09:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,80085000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,21924000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,2230000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,12958000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5084000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,263000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,344000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2261000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,45064000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,882000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,16351000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,13939000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,30290000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,,totalassets,Total Assets,=,debit,usd,76236000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3328000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8206000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4072000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,3500000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,19106000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6512000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4959000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,41471000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,60577000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,387467000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-371848000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,40000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,15659000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,15659000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,15659000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,,2012-06-30,2012-08-08 15:44:02+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,76236000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,23959000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,300000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,17062000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3768000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,263000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,826000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,404000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,46582000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,751000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2513000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,14248000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,16761000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,,totalassets,Total Assets,=,debit,usd,64094000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2293000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8035000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1308000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,928000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,12564000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6215000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,5531000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,41746000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,54310000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,391292000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-381548000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,40000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,9784000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,9784000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,9784000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,,2012-09-30,2012-11-08 16:47:03+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,64094000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,14805000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,616000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,13462000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4325000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1781000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,418000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,35407000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,486000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,11006000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,11006000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,,totalassets,Total Assets,=,debit,usd,46899000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1073000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5647000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1536000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,3068000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11324000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5624000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2791000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,38415000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,49739000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,394252000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-397107000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,15000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-2840000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-2840000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-2840000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,,2013-03-31,2013-05-09 16:04:02+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,46899000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,19767000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,2129000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,9358000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1024000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1179000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,73000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,33530000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,425000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5961000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5961000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,,totalassets,Total Assets,=,debit,usd,39916000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,989000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5773000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1538000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,3658000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11958000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5327000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1678000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,37005000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,48963000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,400226000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-409279000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,6000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-9047000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-9047000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-9047000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,,2013-06-30,2013-08-08 16:33:22+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,39916000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,26050000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,150000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,16541000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2369000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1656000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,73000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,46839000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,359000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,680000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5327000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,6007000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,,totalassets,Total Assets,=,debit,usd,53205000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1241000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7668000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1539000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,2734000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13182000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5032000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1581000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,36613000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,49795000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,420688000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-417280000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,2000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,3410000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,3410000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,3410000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,,2013-09-30,2013-11-08 14:42:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,53205000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,13584000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,150000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,17807000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3280000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,835000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,75000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,35731000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,260000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2679000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4717000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,7396000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,,totalassets,Total Assets,=,debit,usd,43387000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1352000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6312000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1473000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,4552000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13689000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4440000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,981000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,35421000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,49110000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,427121000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-432846000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,2000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-5723000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-5723000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-5723000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,,2014-03-31,2014-05-09 14:26:54+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,43387000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,121519000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,150000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,10589000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,897000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5020000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,75000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,138250000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,216000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,602000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2907000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3509000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,,totalassets,Total Assets,=,debit,usd,141975000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,30000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2360000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7309000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1482000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,3786000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,44937000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4144000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2805000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,6949000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,51886000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,537581000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-447495000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,3000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,90089000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,90089000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,90089000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,,2014-06-30,2014-08-08 15:29:33+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,141975000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,121157000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,150000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,5977000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3238000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4546000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,76000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,135144000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,210000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,302000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1469000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1771000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,,totalassets,Total Assets,=,debit,usd,137125000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,30000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2266000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,11252000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1481000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,4824000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,49823000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3848000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,3848000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,53671000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,539678000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-456226000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,2000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,83454000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,83454000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,83454000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,,2014-09-30,2014-11-07 16:13:10+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,137125000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,76781000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1569000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,17584000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4296000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1308000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5449000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,101000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,107088000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1047000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,36059000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5987000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,42046000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,,totalassets,Total Assets,=,debit,usd,150181000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3822000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,19001000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6499000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,30000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,4450000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,63772000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,10320000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,10320000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,74092000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,554342000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-478161000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-92000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,76089000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,76089000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,76089000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,,2015-06-30,2015-08-07 16:29:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,150181000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,46627000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1622000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,23700000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7495000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4970000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,88000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,84502000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1146000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,47787000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5521000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,53308000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,,totalassets,Total Assets,=,debit,usd,138956000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3782000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,23027000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2118000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,30000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,5517000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,64444000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,10467000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,10467000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,74911000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,556828000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-492782000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,64045000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,64045000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,64045000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,,2015-09-30,2015-11-06 16:12:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,138956000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,12902000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1965000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,22914000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7384000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1949000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3221000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,90000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,50425000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,8362000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,41134000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2960000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,44094000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,,totalassets,Total Assets,=,debit,usd,102881000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,27914000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7691000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,17328000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2163000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,7974000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,63070000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,2506000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,9507000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,12013000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,75083000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,561499000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-533749000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,48000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,27798000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,27798000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,27798000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,,2016-03-31,2016-05-09 14:04:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,102881000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,8661000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,4426000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,27079000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2234000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1949000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1674000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,89000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,46112000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,10112000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,24154000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1839000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,25993000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,,totalassets,Total Assets,=,debit,usd,82217000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,28023000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5051000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,11783000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2134000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,9203000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,56194000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,2589000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,9073000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,974000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,12636000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,68830000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,563371000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-550030000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,46000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,13387000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,13387000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,13387000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,,2016-06-30,2016-08-08 15:40:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,82217000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,35387000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1506000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,17434000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5968000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,2232000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2007000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,98000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,64632000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,10095000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,14371000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2404000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,16775000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,,totalassets,Total Assets,=,debit,usd,91502000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,28133000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2760000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,10782000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2282000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,7563000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,51520000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,22665000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,2675000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,8745000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1904000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,35989000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,87509000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,565529000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-561558000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,22000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,3993000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,3993000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,3993000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,,2016-09-30,2016-11-08 14:23:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,91502000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,75158000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,2798000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,23524000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,9564000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,655000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1721000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,82000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,113502000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,9753000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3803000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2455000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,6258000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,,totalassets,Total Assets,=,debit,usd,129513000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,29629000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5433000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,11335000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1869000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,10291000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,58557000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,21611000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,2704000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,8111000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,32426000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,90983000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,618813000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-580280000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-3000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,38530000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,38530000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,38530000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,,2017-03-31,2017-05-08 15:02:04+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,129513000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,39696000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,5357000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,40977000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3325000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1305000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1524000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,79000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,92263000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,9602000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,9603000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2041000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,11644000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,,totalassets,Total Assets,=,debit,usd,113509000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,31460000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1844000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12329000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1717000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,11587000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,58937000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,19999000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,2704000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,7793000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,30496000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,89433000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,621257000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-597166000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-15000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,24076000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,24076000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,24076000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,,2017-06-30,2017-08-08 14:03:39+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,113509000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,117776000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,3122000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,43848000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,8985000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1421000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,218000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,175370000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,9613000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,4539000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1970000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,6509000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,,totalassets,Total Assets,=,debit,usd,191492000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,33372000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4603000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,11871000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,8686000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,10705000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,69237000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,18379000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,2770000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,474000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,21623000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,90860000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,712949000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-612300000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-17000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,100632000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,100632000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,100632000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,,2017-09-30,2017-11-08 15:14:11+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,191492000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,43767000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,4599000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,47540000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5694000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,7000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2397000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,152000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,104156000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,9395000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,41599000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,222000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,41821000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,,totalassets,Total Assets,=,debit,usd,155372000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,35365000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3588000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,15624000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,7300000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,13465000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,75342000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,15114000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,2731000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,131000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,17976000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,93318000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,719024000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-656494000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-476000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,62054000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,62054000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,62054000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,,2018-03-31,2018-05-09 14:10:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,155372000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,27104000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,7625000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,53636000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2342000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,221000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1729000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,12000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,92669000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,9390000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,33744000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,841000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,34585000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,,totalassets,Total Assets,=,debit,usd,136644000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,35510000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4122000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,19409000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,300000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,14832000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,74173000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,13469000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,2711000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,107000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,16287000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,90460000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,721576000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-674940000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-452000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,46184000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,46184000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,46184000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,,2018-06-30,2018-08-09 14:19:43+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,136644000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,52584000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1506000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,67737000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3394000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,821000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2445000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,8000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,128495000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,9236000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,29157000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1420000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,30577000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,,totalassets,Total Assets,=,debit,usd,168308000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,30699000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7911000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,15120000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,200000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,10427000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,64357000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,28293000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,2704000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,81000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,31078000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,95435000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,777820000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-704537000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-410000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,72873000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,72873000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,72873000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,,2018-09-30,2018-11-08 15:15:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,168308000.0
